Your browser doesn't support javascript.
loading
Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability.
Berry, James D; Paganoni, Sabrina; Atassi, Nazem; Macklin, Eric A; Goyal, Namita; Rivner, Michael; Simpson, Ericka; Appel, Stanley; Grasso, Daniela L; Mejia, Nicte I; Mateen, Farrah; Gill, Alan; Vieira, Fernando; Tassinari, Valerie; Perrin, Steven.
Afiliação
  • Berry JD; Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 600, Boston, Massachusetts, 02114, USA.
  • Paganoni S; Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.
  • Atassi N; Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 600, Boston, Massachusetts, 02114, USA.
  • Macklin EA; Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.
  • Goyal N; Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 600, Boston, Massachusetts, 02114, USA.
  • Rivner M; Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.
  • Simpson E; Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 600, Boston, Massachusetts, 02114, USA.
  • Appel S; Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.
  • Grasso DL; Department of Neurology, University of California, Irvine, Orange, California, USA.
  • Mejia NI; Department of Neurology, Augusta University Medical Center, Augusta, Georgia, USA.
  • Mateen F; Department of Neurology, Methodist Hospital, Houston, Texas, USA.
  • Gill A; Department of Neurology, Methodist Hospital, Houston, Texas, USA.
  • Vieira F; Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 600, Boston, Massachusetts, 02114, USA.
  • Tassinari V; Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 600, Boston, Massachusetts, 02114, USA.
  • Perrin S; Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 600, Boston, Massachusetts, 02114, USA.
Muscle Nerve ; 56(6): 1077-1084, 2017 Dec.
Article em En | MEDLINE | ID: mdl-28662296
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cloridrato de Fingolimode / Esclerose Lateral Amiotrófica / Imunossupressores Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cloridrato de Fingolimode / Esclerose Lateral Amiotrófica / Imunossupressores Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos